Donate

News

Latest news

Updates from Recent Clinical Trials in Multiple Myeloma

April 9, 2021,

Australian myeloma registry highlights challenges of adhering to best practice

April 3, 2021,

Article of the week

March 28, 2021,

Myeloma Research Review – Issue 37

March 28, 2021,

Auckland Myeloma Patient Seminar

March 26, 2021,

Multiple Myeloma 101: An Incurable But ‘Very Treatable’ Disease

March 24, 2021,

Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two‐centre Australian experience

March 17, 2021,

Multiple myeloma is not easily diagnosed.

March 15, 2021,

Patient Perceptions Regarding Multiple Myeloma and Its Treatment: Qualitative Evidence from Interviews with Patients in the United Kingdom, France, and Germany

March 12, 2021,

Newsletter: Autumn 2021

March 10, 2021,

Riding the Alps 2 Ocean cycle trail.

March 5, 2021,

Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition

February 16, 2021,

Myeloma Interest Group | Article & IMS COVID-19 Vaccination Recommendations

February 12, 2021, ,

Relationship Between Insurance Type and Survival in Multiple Myeloma

February 11, 2021,

Patients’ socioeconomic status is a significant factor in predicting survival rates for multiple myeloma, according to a new study.

February 9, 2021,

Cancer in New Zealand: Haematologist calls for increased funding towards blood cancer treatments

February 4, 2021,

International Data on Multiple Myeloma Link Socioeconomic Status to Mortality

January 29, 2021,

Colorectal Cancer in a Patient With Multiple Myeloma: A Treatment Dilemma

January 27, 2021,

Large Meta-Analysis Confirms Predictive Value of MRD Negativity in Myeloma

January 20, 2021,

Smoldering multiple myeloma 40 years later: a story of unintended disease

January 13, 2021,

Higher Rates of COVID-19 Mortality for Patients with Multiple Myeloma

January 8, 2021, ,

Saad Z. Usmani, MD, MBA, FACP, on the Latest in Multiple Myeloma Research

January 7, 2021,

Insurance Status Linked to Survival for Patients with Multiple Myeloma

January 5, 2021,

A Beginner’s Guide to Understanding Myeloma

December 21, 2020,

Understanding New Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

December 16, 2020,

Subcut daratumumab: reducing treatment burden in myeloma

December 11, 2020, ,

Phase III Trial Supports Efficacy of Subcutaneous Daratumumab in Relapsed/Refractory Myeloma

December 10, 2020,

Year in Review: Multiple Myeloma

December 3, 2020,

Myeloma Research Review – issue 36

December 2, 2020,

Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies

December 2, 2020, ,

Newsletter: Summer 2020

December 1, 2020,

MM management in Australia lags behind other countries due to reimbursement model

November 18, 2020,

Bridging Radiation Therapy Safe, Feasible for Patients with R/R Multiple Myeloma

November 17, 2020,

Multicenter Study of Spanish Patients Provides New Insights on COVID-19 in Multiple Myeloma

November 13, 2020, ,

Multiple myeloma-A painful disease of the bone marrow

November 10, 2020,

Hematologist Discusses the Multiple Myeloma Pipeline

November 6, 2020,

Saad Usmani Discusses Treatments in Multiple Myeloma Patients.

November 5, 2020,

A Look at the Immunotherapy Pipeline for Multiple Myeloma

November 2, 2020,

Whangarei Myeloma Seminar – 23 November 2020

October 26, 2020,

Optimal Strategies for Treatment of Multiple Myeloma in Newly Diagnosed Patients

October 12, 2020,

Daratumumab gets PBS listing recommendation after ‘disgraceful’ delay

October 12, 2020,

Chatham cancer survivor inspires multiple myeloma patients

October 2, 2020,

Multiple Myeloma March tackles low awareness, boosts research

September 30, 2020

New partnership aims to advance predictive tests for multiple myeloma in Ireland

September 21, 2020,

Crohn’s and Colitis NZ patient support group requests your support

September 21, 2020

New myeloma study

September 21, 2020

Drug Exposure, Disease Characteristics Not Linked to Increased Mortality Risk in Patients with Multiple Myeloma Who Contracted COVID-19

September 18, 2020,

Exploring the Future of CAR T-Cell Therapy in Multiple Myeloma

September 18, 2020,

Novel Agents Rouse Responses in Relapsed/Refractory Multiple Myeloma

September 18, 2020,

Despite COVID-19 limitations, fundraiser for multiple myeloma finds a way

September 14, 2020, ,